title: Concurrent chemoradiation in locally advanced carcinoma cervix patients.
abstract: OBJECTIVE
  To investigate the feasibility of concurrent chemo radiation in locally advanced carcinoma cervix patients in our clinical setting.
  
  
  METHODS
  From Sept. 1st 2005 to Aug. 31st 2006, 102 patients of carcinoma cervix belonging to stage IIA to IV A were enrolled in the study. External beam radiation therapy was administered using Cobalt 60 teletherapy machine. Cisplatinum (40 mg/m 2) and 5 Fluorouracil (500 mg/m 2 ) continuous infusions with radiotherapy on D2-D5 in first and last 5 # of radiation therapy were administered.
  
  
  RESULTS
  Response to treatment and toxicities were monitored and analyzed in 102 patients (50 study group and 52 control group). All 102 patients completed treatment. Out of 50 patients in the study group, 30, 10 and 4 patients had complete, partial and progressive disease, respectively. While out of 52 patients in the control group, 26 had complete and 12 showed partial response. No difference in overall renal, hematological and cutaneous toxicity was seen between two groups.
  
  
  CONCLUSIONS
  This study did not show any benefit of concurrent chemo radiation as compared to radiotherapy alone in locally advanced cervical cancer patients. This could be due to more bulk of tumor stage per stage, poor nutritional status, less number of patients in both arms, not enough to pick up statistically significant small difference in outcome.
authors.affiliation: Department of Radiotherapy & Oncology, IGMC, Shimla, HP, India.
authors.forename: R R
authors.initials: RR
authors.lastname: Negi
authors.forename: Manish
authors.initials: M
authors.lastname: Gupta
authors.forename: Muninder
authors.initials: M
authors.lastname: Kumar
authors.forename: M K
authors.initials: MK
authors.lastname: Gupta
authors.forename: R
authors.initials: R
authors.lastname: Seam
authors.forename: Madhup
authors.initials: M
authors.lastname: Rastogi
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy; D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy; D002945:Cisplatin / Q000008:administration & dosage; D003037:Cobalt Radioisotopes / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D005240:Feasibility Studies; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D008875:Middle Aged; D009367:Neoplasm Staging; D011879:Radiotherapy Dosage; D015996:Survival Rate; D016896:Treatment Outcome; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy*
chemical_list: D003037:Cobalt Radioisotopes; D002945:Cisplatin; D005472:Fluorouracil